105 related articles for article (PubMed ID: 1385192)
1. Platelet-derived growth factor (PDGF) receptor activation in cell transformation and human malignancy.
Fleming TP; Matsui T; Aaronson SA
Exp Gerontol; 1992; 27(5-6):523-32. PubMed ID: 1385192
[TBL] [Abstract][Full Text] [Related]
2. Compartmentalization of autocrine signal transduction pathways in Sis-transformed NIH 3T3 cells.
Valgeirsdóttir S; Eriksson A; Nistér M; Heldin CH; Westermark B; Claesson-Welsh L
J Biol Chem; 1995 Apr; 270(17):10161-70. PubMed ID: 7730319
[TBL] [Abstract][Full Text] [Related]
3. Autocrine mechanism for v-sis transformation requires cell surface localization of internally activated growth factor receptors.
Fleming TP; Matsui T; Molloy CJ; Robbins KC; Aaronson SA
Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8063-7. PubMed ID: 2813378
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of an activated platelet-derived growth factor autocrine pathway and its role in human tumor cell proliferation in vitro.
Fleming TP; Matsui T; Heidaran MA; Molloy CJ; Artrip J; Aaronson SA
Oncogene; 1992 Jul; 7(7):1355-9. PubMed ID: 1320245
[TBL] [Abstract][Full Text] [Related]
5. Rapid turnover of the platelet-derived growth factor receptor in sis-transformed cells and reversal by suramin. Implications for the mechanism of autocrine transformation.
Huang SS; Huang JS
J Biol Chem; 1988 Sep; 263(25):12608-18. PubMed ID: 2842336
[TBL] [Abstract][Full Text] [Related]
6. Suramin enters and accumulates in low pH intracellular compartments of v-sis-transformed NIH 3T3 cells.
Huang SS; Koh HA; Huang JS
FEBS Lett; 1997 Oct; 416(3):297-301. PubMed ID: 9373173
[TBL] [Abstract][Full Text] [Related]
7. Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line.
Vassbotn FS; Ostman A; Langeland N; Holmsen H; Westermark B; Heldin CH; Nistér M
J Cell Physiol; 1994 Feb; 158(2):381-9. PubMed ID: 8106574
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.
Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Regenass U; Lydon NB
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2558-62. PubMed ID: 7708684
[TBL] [Abstract][Full Text] [Related]
9. Blockade of autocrine stimulation in simian sarcoma virus-transformed cells reverses down-regulation of platelet-derived growth factor receptors.
Garrett JS; Coughlin SR; Niman HL; Tremble PM; Giels GM; Williams LT
Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7466-70. PubMed ID: 6095298
[TBL] [Abstract][Full Text] [Related]
10. PDGF-independent activation of PDGF-beta receptors in NIH-3T3 cells transformed by c-met protooncogene.
Kochhar KS; Linnekin D; Iyer AP
Exp Cell Res; 1994 Jun; 212(2):414-21. PubMed ID: 7514539
[TBL] [Abstract][Full Text] [Related]
11. Growth factor PDGF-B/v-sis confers a tumorigenic phenotype to human tumor cells bearing PDGF receptors but not to cells devoid of receptors: evidence for an autocrine, but not a paracrine, mechanism.
Potapova O; Fakhrai H; Mercola D
Int J Cancer; 1996 May; 66(5):669-77. PubMed ID: 8647631
[TBL] [Abstract][Full Text] [Related]
12. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172).
Ahn HY; Hadizadeh KR; Seul C; Yun YP; Vetter H; Sachinidis A
Mol Biol Cell; 1999 Apr; 10(4):1093-104. PubMed ID: 10198059
[TBL] [Abstract][Full Text] [Related]
13. Intracellular retention of membrane-anchored v-sis protein abrogates autocrine signal transduction.
Lee BA; Donoghue DJ
J Cell Biol; 1992 Sep; 118(5):1057-70. PubMed ID: 1324943
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of platelet-derived growth factor (PDGF) receptor autophosphorylation and PDGF-mediated cellular events by a quinoline derivative.
Yagi M; Kato S; Kobayashi Y; Kubo K; Oyama S; Shimizu T; Nishitoba T; Isoe T; Nakamura K; Ohashi H; Kobayashi N; Iinuma N; Osawa T; Onose R; Osada H
Exp Cell Res; 1997 Aug; 234(2):285-92. PubMed ID: 9260896
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
Schrell UM; Gauer S; Kiesewetter F; Bickel A; Hren J; Adams EF; Fahlbusch R
J Neurosurg; 1995 Apr; 82(4):600-7. PubMed ID: 7897522
[TBL] [Abstract][Full Text] [Related]
16. Effects of trapidil and suramin on growth factor-induced calcium response and tyrosine phosphorylation in human glioma cells.
Bando K; Kannuki S; Rokutan K; Shouno M; Matsumoto K
Neurol Med Chir (Tokyo); 1995 Sep; 35(9):631-8. PubMed ID: 7566395
[TBL] [Abstract][Full Text] [Related]
17. Pool of ligand-bound platelet-derived growth factor beta-receptors remain activated and tyrosine phosphorylated after internalization.
Sorkin A; Eriksson A; Heldin CH; Westermark B; Claesson-Welsh L
J Cell Physiol; 1993 Aug; 156(2):373-82. PubMed ID: 7688373
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor in human malignancy.
Silver BJ
Biofactors; 1992 Apr; 3(4):217-27. PubMed ID: 1318717
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta stimulates rat mesangial cell proliferation in culture: role of PDGF beta-receptor expression.
Haberstroh U; Zahner G; Disser M; Thaiss F; Wolf G; Stahl RA
Am J Physiol; 1993 Feb; 264(2 Pt 2):F199-205. PubMed ID: 8447432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]